Author: Money Morning Staff

Shares have the potential to jump 116% higher over the next year.

All three have a remarkable drug pipeline that should net them massive profits. And our top stock has upside of more than 100% in the next few months.

Our top pick could double in price.

It’s not only a bargain right now — it’s on the verge of ripping higher in the months ahead.

We think it could rocket nearly 200% higher.